Carbohydrate antigen 27.29

Known as: 27 29 ca, ca 27 29, ca 27.29 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-2009
01219922009

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
BACKGROUND Several trials show that tumor markers at primary diagnosis of cancer have prognostic relevance and can predict… (More)
  • figure 1
  • table I
Is this relevant?
2009
2009
Within the past decade, the incidence of breast cancer in Taiwan has been rising year after year. Breast cancer is the first most… (More)
  • table I
  • table II
  • figure 1
  • table III
  • table IV
Is this relevant?
Review
2009
Review
2009
e11579 Background: ASCO guidelines do not support the use of CA 15-3 and CA 27.29 for monitoring patients for recurrence after… (More)
Is this relevant?
2004
2004
805 Background: In 2003, Citron et al. published the results of the C9741 trial showing an improvement of outcome for dose-dense… (More)
Is this relevant?
Review
2004
Review
2004
CONTEXT There are 2 general types of assays measuring MUC1 gene-derived glycoprotein: assays for cancer antigen (CA) 15-3, which… (More)
Is this relevant?
Review
1999
Review
1999
A critical review of CA 27.29 and CA 15-3 is performed in this paper. A review of the literature is undertaken. A review of the… (More)
Is this relevant?
1995
1995
Serum levels of CEA, CA 15.3 and CA 27.29 were measured during the follow-up of 499 breast cancer patients. Studies included… (More)
Is this relevant?
1992
1992
Evaluation of a radioimmunoassay for a new tumor marker, named CA 27.29, recently proposed for use in breast cancer patients, is… (More)
Is this relevant?